CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major

Journal of Experimental Medicine

Volumn 179, Issue 4, 1994, Pages 1367-1371

  Wang, Zhi En ^a   Reiner, Steven L ^a   Zheng, Shichun ^a   Dalton, Dyana K ^b   Locksley, Richard M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL TISSUE; ARTICLE; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENE SEQUENCE; HELPER CELL; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0028326103     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.179.4.1367     Document Type: Article

References (27)

1. Mosmann, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
2. + T cells producing IL-2 or IL-4. J. Immunol. 148:1031.
3. Hsieh, C.-S., A.B. Heimberger, J.S. Gold, A. O'Garra, and K.M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:6065.
4. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
5. Heinzel, F.P., M.D. Sadick, B.J. Holaday, R.L. Coffman, and R.M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
6. Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (Lond.). 362:245.
7. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science (Wash. DC). 259:1739.
8. Sadick, M.D., F.P. Heinzel, B.J. Holaday, R.T. Pu, R.S. Dawkins, and R.M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. Med. 171:115.
9. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA. 88:7011.
10. Reiner, S.L., S. Zheng, D.B. Corry, and R.M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:37.
11. Li, C.-B., P.W. Gray, P.-F. Lin, K.M. McGrath, F.H. Ruddle, and N.H. Ruddle. 1987. Cloning and expression of murine lymphotoxin cDNA. J. Immunol. 138:4496.
12. McKenzie, A.N.J., X. Li, D.A. Largaespada, A. Sato, A. Kaneda, S.M. Zurawski, E.L. Doyle, A. Milatovich, U. Francke, N.G. Copeland, et al. 1993. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J. Immunol. 150:5436.
13. Gessner, A., D. Moskophidis, and F. Lehmann-Grube. 1989. Enumeration of single IFN-γ-producing cells in mice during viral and bacterial infection. J. Immunol. 142:1293.
14. Finkelman, F.D., J. Holmes, I.M. Katona, J.F. Urban, M.P. Beckmann, L.S. Park, K.A. Schooley, R.L. Coffman, T.R. Mossman, and W.E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
15. Le Gros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
16. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547.
18. Manetti, R., P. Parronchi, M.G. Giudizi, M.-P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
19. + αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:371.
20. Maggi, E., P. Parronchi, R. Manetti, C. Simonelli, M.-P. Piccinni, F.S. Rugiu, M. De Carli, M. Ricci, and S. Romagnani. 1992. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148:2142.
21. Belosevic, M., D.S. Finbloom, P.H. van der Meide, M.V. Slayter, and C.A. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266.
22. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.
23. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bleuthmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science (Wash. DC). 259:1742.
24. Kamijo, R., J. Le, D. Shapiro, E.A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilček. 1993. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435.
25. Tanaka, T., J. Hu-Li, R.A. Seder, B. Fazekas de St. Groth, and W.E. Paul. 1993. Interleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. USA. 90:5914.
26. Gajewski, T.F., and F.W. Fitch. 1988. Antiproliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245.
27. Reiner, S.L., Z.E. Wang, F. Hatam, P. Scott, and R.M. Locksley. 1993. Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science (Wash. DC). 259:1457.